K. Chrystal

421 total citations
17 papers, 249 citations indexed

About

K. Chrystal is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Surgery. According to data from OpenAlex, K. Chrystal has authored 17 papers receiving a total of 249 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Pulmonary and Respiratory Medicine, 6 papers in Oncology and 5 papers in Surgery. Recurrent topics in K. Chrystal's work include Gastric Cancer Management and Outcomes (5 papers), Ovarian cancer diagnosis and treatment (5 papers) and Lung Cancer Treatments and Mutations (5 papers). K. Chrystal is often cited by papers focused on Gastric Cancer Management and Outcomes (5 papers), Ovarian cancer diagnosis and treatment (5 papers) and Lung Cancer Treatments and Mutations (5 papers). K. Chrystal collaborates with scholars based in United Kingdom, New Zealand and Canada. K. Chrystal's co-authors include Richard Isaacs, Garry Forgeson, Simon Allan, Peter Harper, T.A. Plunkett, Michelle Wilson, Helen Mackay, Lisa Wang, Kathryn Payne and Marjan Rouzbahman and has published in prestigious journals such as Journal of Clinical Oncology, Annals of Oncology and Gynecologic Oncology.

In The Last Decade

K. Chrystal

17 papers receiving 237 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
K. Chrystal United Kingdom 7 88 73 57 51 43 17 249
C. Sheanakul Thailand 10 35 0.4× 15 0.2× 198 3.5× 14 0.3× 228 5.3× 13 351
Hongxuan Tong China 9 43 0.5× 67 0.9× 10 0.2× 37 0.7× 18 0.4× 25 252
Michael D. Scheiber United States 9 4 0.0× 55 0.8× 80 1.4× 7 0.1× 28 0.7× 18 397
Jan Neuman Canada 6 4 0.0× 21 0.3× 74 1.3× 28 0.5× 45 1.0× 12 325
Marcio José Concepción‐Zavaleta Peru 10 6 0.1× 13 0.2× 21 0.4× 7 0.1× 46 1.1× 51 224
Luis Alberto Concepción‐Urteaga Peru 9 6 0.1× 12 0.2× 20 0.4× 8 0.2× 39 0.9× 44 202
Ilkyun Lee South Korea 7 6 0.1× 158 2.2× 4 0.1× 38 0.7× 17 0.4× 18 300
Behnaz Khani Iran 8 6 0.1× 5 0.1× 211 3.7× 10 0.2× 25 0.6× 21 318
T. Rabe Germany 8 3 0.0× 14 0.2× 53 0.9× 15 0.3× 18 0.4× 37 271
Richard Viskochil United States 8 27 0.3× 51 0.7× 6 0.1× 14 0.3× 14 0.3× 16 195

Countries citing papers authored by K. Chrystal

Since Specialization
Citations

This map shows the geographic impact of K. Chrystal's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by K. Chrystal with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites K. Chrystal more than expected).

Fields of papers citing papers by K. Chrystal

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by K. Chrystal. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by K. Chrystal. The network helps show where K. Chrystal may publish in the future.

Co-authorship network of co-authors of K. Chrystal

This figure shows the co-authorship network connecting the top 25 collaborators of K. Chrystal. A scholar is included among the top collaborators of K. Chrystal based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with K. Chrystal. K. Chrystal is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Wong, Ee Ming, et al.. (2019). Implementation of mainstream BRCA testing in epithelial ovarian cancer in a tertiary centre. Annals of Oncology. 30. ix81–ix81. 1 indexed citations
2.
Wilson, Michelle, Peter C.C. Fong, Soizick Mesnage, et al.. (2015). Stage I granulosa cell tumours: A management conundrum? Results of long-term follow up. Gynecologic Oncology. 138(2). 285–291. 45 indexed citations
3.
Chrystal, K., et al.. (2014). Familial HCG syndrome: A diagnostic challenge. Gynecologic Oncology Reports. 10. 47–48. 5 indexed citations
4.
Sykes, Peter, Michelle Vaughan, K. Chrystal, et al.. (2012). Providing care for women with gynaecological malignancy: the need for a coordinated national approach.. PubMed. 125(1360). 57–65. 2 indexed citations
5.
Karapetis, Christos S., Desmond Yip, Andrew Strickland, et al.. (2010). A phase I and II trial of epirubicin, cisplatin, 24‐hour infusion 5 fluorouracil and sodium folinate in patients with advanced esophagogastric carcinomas. Asia-Pacific Journal of Clinical Oncology. 6(4). 298–305. 4 indexed citations
6.
Chrystal, K., et al.. (2006). Adjuvant chemotherapy in non-small cell lung cancer. International Journal of Clinical Practice. 61(1). 143–146. 2 indexed citations
7.
8.
9.
Chrystal, K., et al.. (2006). The management of PS2 patients with advanced non-small cell lung cancer. International Journal of Clinical Practice. 60(11). 1493–1496. 3 indexed citations
10.
Forshaw, M. J., James Gossage, K. Chrystal, et al.. (2006). Neoadjuvant chemotherapy for locally advanced carcinoma of the lower oesophagus and oesophago-gastric junction. European Journal of Surgical Oncology. 32(10). 1114–1118. 12 indexed citations
11.
Chrystal, K., et al.. (2006). Management of the elderly patient with advanced 
non-small cell lung cancer. International Journal of Clinical Practice. 60(3). 340–343. 9 indexed citations
12.
Chrystal, K., et al.. (2004). Chemotherapy of small cell lung cancer: state of the art. Current Opinion in Oncology. 16(2). 136–140. 22 indexed citations
13.
Chrystal, K., Christopher Steer, Eleni Galani, et al.. (2004). Gemcitabine and oxaliplatin followed by paclitaxel and carboplatin as first line therapy for patients with advanced epithelial ovarian cancer. A phase II trial of sequential doublets. (GO-FIRST). Journal of Clinical Oncology. 22(14_suppl). 5034–5034. 3 indexed citations
14.
Chrystal, K., Christopher Steer, Eleni Galani, et al.. (2004). Gemcitabine and oxaliplatin followed by paclitaxel and carboplatin as first line therapy for patients with advanced epithelial ovarian cancer. A phase II trial of sequential doublets. (GO-FIRST). Journal of Clinical Oncology. 22(14_suppl). 5034–5034. 1 indexed citations
15.
Chrystal, K., James Gossage, Eleni Galani, et al.. (2004). Neoadjuvant chemotherapy in “technically” inoperable locally advanced oesophageal (O) and gastro-oesophageal junction (GOJ) cancer. Journal of Clinical Oncology. 22(14_suppl). 4138–4138. 1 indexed citations
16.
Plunkett, T.A., K. Chrystal, & Peter Harper. (2003). Quality of Life and the Treatment of Advanced Lung Cancer. Clinical Lung Cancer. 5(1). 28–32. 24 indexed citations
17.
Chrystal, K., Simon Allan, Garry Forgeson, & Richard Isaacs. (2003). The use of complementary/alternative medicine by cancer patients in a New Zealand regional cancer treatment centre.. PubMed. 116(1168). U296–U296. 102 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by C. Sheanakul Breakdown of academic impact, for papers by Hongxuan Tong Breakdown of academic impact, for papers by Michael D. Scheiber Breakdown of academic impact, for papers by Jan Neuman Breakdown of academic impact, for papers by Marcio José Concepción‐Zavaleta Breakdown of academic impact, for papers by Luis Alberto Concepción‐Urteaga Breakdown of academic impact, for papers by Ilkyun Lee Breakdown of academic impact, for papers by Behnaz Khani Breakdown of academic impact, for papers by T. Rabe Breakdown of academic impact, for papers by Richard Viskochil
Rankless by CCL
2026